<DOC>
	<DOC>NCT01396252</DOC>
	<brief_summary>The purpose of this clinical study is to assess the safety and tolerability of multiple oral doses of BMS-820836 in healthy Japanese subjects and Japanese patients with depression.</brief_summary>
	<brief_title>Japanese Phase 1 Multiple Ascending Dose (MAD) Study</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>Healthy Japanese subjects and Japanese patients with depression (Hamilton Rating Scale for Depression (HAMD) â‰¥ 14), ages 20 to 55 years. Any significant acute or chronic medical illness. Noncompliance, or overall not suitable as determined by the investigator. History of, or current clinically significant psychiatric disorders or illnesses, substance abuse or dependence.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>